Delayed Thrombotic Complications in a Thrombotic Thrombocytopenic Purpura Patient Treated With Caplacizumab

Thrombotic thrombocytopenic purpura (TTP) is a rare and unpredictable disease with a high mortality rate (90%) if untreated. It results from systemic microvascular thrombosis and leads to profound thrombocytopenia, hemolytic anemia and organ failure of varying severity. However, macrovascular thromb...

Descripción completa

Detalles Bibliográficos
Autores principales: Cilla, Nicolas, Dallemagne, Julie, Vanhove, Marie, Stordeur, Patrick, Motte, Serge, De Wilde, Virginie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430863/
https://www.ncbi.nlm.nih.gov/pubmed/32855757
http://dx.doi.org/10.14740/jh614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430863/
https://www.ncbi.nlm.nih.gov/pubmed/32855757
http://dx.doi.org/10.14740/jh614

Ejemplares similares